Hostname: page-component-586b7cd67f-tf8b9 Total loading time: 0 Render date: 2024-11-24T05:57:05.548Z Has data issue: false hasContentIssue false
  • English
  • Français

Factors associated with delays in head and neck cancer treatment: case–control study

Published online by Cambridge University Press:  19 March 2015

R Nash ,
J Hughes ,
A Sandison ,
S Stewart ,
P Clarke  and
A Mace
R Nash*
Affiliation:
Department of Head and Neck Surgery, Charing Cross Hospital, London, UK
J Hughes
Affiliation:
Department of Head and Neck Surgery, Charing Cross Hospital, London, UK
A Sandison
Affiliation:
Department of Histopathology, Charing Cross Hospital, London, UK
S Stewart
Affiliation:
Department of Oncology, Charing Cross Hospital, London, UK
P Clarke
Affiliation:
Department of Head and Neck Surgery, Charing Cross Hospital, London, UK
A Mace
Affiliation:
Department of Head and Neck Surgery, Charing Cross Hospital, London, UK
*
Address for correspondence: Mr Robert Nash, Department of Head and Neck Surgery, Charing Cross Hospital, London, UK E-mail: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

Background:

Delays in head and neck cancer treatment lead to increased mortality, more extensive treatment and patient anxiety. We aim to treat all patients with cancer within 62 days of receipt of a referral. An analysis was conducted of those patients whose treatment had been delayed in order to identify factors associated with treatment delay.

Methods:

In this retrospective case–control study, 50 patients whose treatment was delayed were identified and compared with 50 patients whose treatment was not delayed. Individual factors assessed included patient age, co-morbidity, tumour location and stage, the treatment agreed, the hospitals to which the patients were referred, and the clinicians they saw.

Results:

There was a significant association between referral to a non-head and neck cancer centre, or review by a non-head and neck multidisciplinary team member, and treatment delay.

Conclusion:

In the context of centralisation of head and neck cancer services, it is important to consider delays that may be associated with a ‘hub and spoke’ model of service provision.

Keywords

Head And Neck NeoplasmsSecondary Care CentersDelivery Of Health Care
Type
Main Articles
Information
The Journal of Laryngology & Otology , Volume 129 , Issue 4 , April 2015 , pp. 383 - 385
Copyright
Copyright © JLO (1984) Limited 2015 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1Esmaelbeigi, F, Hadji, M, Harirchi, I, Omranipour, R, Vand Rajabpour, M, Zendehdel, K. Factors affecting professional delay in diagnosis and treatment of oral cancer in Iran. Arch Iran Med 2014;17:253–7Google ScholarPubMed
2Teppo, H, Alho, OP. Comorbidity and diagnostic delay in cancer of the larynx, tongue and pharynx. Oral Oncol 2009;45:692–5Google Scholar
3Xie, C, Mills, H, Magill, J, Randhawa, PS, Mace, AD, Clarke, PM et al. Reducing treatment delay by improving information flow within the multidisciplinary team: a multicycle audit spiral in head and neck cancer. Clin Otolaryngol 2012;37:427–8Google Scholar
4van Harten, MC, de Ridder, M, Hamming-Vrieze, O, Smeele, LE, Balm, AJ, van den Brekel, MW. The association of treatment delay and prognosis in head and neck squamous cell carcinoma (HNSCC) patients in a Dutch comprehensive cancer center. Oral Oncol 2014;50:282–90CrossRefGoogle Scholar
5Patel, UA, Brennan, TE. Disparities in head and neck cancer: assessing delay in treatment initiation. Laryngoscope 2012;122:1756–60Google Scholar